BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...


Relentlessly innovative, NuVasive develops and markets minimally disruptive surgical products and procedures for the spine. From its inception, it has focused on creating products, such as its nerve avoidance monitoring system, that contribute to faster, less invasive surgical procedures, speedier recovery times for patients, and shorter hospital stays.
NuVasive went public in 2004.